Conservative management with periodic reevaluations constitutes a safe and effective therapeutic alternative in selected pediatric patients, allowing for the reduction of the need for endoscopic retrograde cholangiopancreatography or biliary tract instrumentation and their associated risks.
Dardanelli et al. (Thu,) studied this question.